Home > Research > Researchers > Jennifer Logue
View graph of relations

Dr Jennifer Logue

Clinical Reader in Metabolic Medicine

Jennifer Logue

Furness Building

LA1 4YG

Lancaster

Tel: +44 1524 595133

Research overview

Jennifer Logue is a Clinical Reader and Honorary Consultant in Metabolic Medicine, focusing both her research and clinical practice on the treatment of obesity and related metabolic disease. Her work focuses on interventions at the level of the individual with the aim of treating or preventing the complications of obesity. This includes interdisiplinary, mixed methods research to develop complex interventions, and pragmatic, efficient clinical trials utilising health record data. Her clinical work includes diabetes, cardiovascular risk factor and obesity clinics alongside clinical biochemistry.

PhD supervision

Dr Logue is happy to hear from potential PhD students interested in the treatment of obesity, developing and evaluating complex interventions, and utilising routine care records.

Career Details

After completing her MD in the University of Glasgow's Department of Surgery, she was awarded a Chief Scientist Office/ NHS Education Scotland Clinician Scientist Intermediate Fellowship in 2011. She moved to Lancaster University in July 2019 with the aim of increasing the interdisplinary and cross-sectorial aspects of her research. 

In early 2019, Dr Logue was selected to be part of the inaugural cohort of the Academy of Medical Sciences FLIER programme. This is an intensive leadership programme, developing leaders who can create collaborations across academia, industry, the NHS and government to drive innovation.

Current Research

She is Chief Investigator of the Surgical Obesity Treatment Study, a NIHR funded longitudinal cohort study of patients undergoing bariatric surgery in Scotland, and Scottish Lead for the NIHR funded study LENS (Lowering Events in Non-proliferative Retinopathy in Scotland). She led a NHS-Pharmaceutical Industry joint working project evaluating the effect of practitioner education on weight management outcomes in patients with type 2 diabetes (Small Talk Big Difference - link below), and a CSO funded core outcome and instrument set development for lifestyle weight management. She is a member of the scientific steering committee for the EU-funded SCORE-IT core outcome set development for trials in type 2 diabetes and an expert advisor for REBALANCE, a NIHR funded systematic review of the evidence base for the management of severe obesity.

Web Links

Professional Role

Ensuring a close relationship between her research and policy, Dr Logue is a member of a number of guideline and policy committees. She was a member of the Scottish Intercollegiate Guideline Network (SIGN) obesity guideline development group, writing the guidance on bariatric surgery. She was a member of the steering committee of Obesity Action Scotland, a committee of the Scottish Academy of Medical Royal Colleges, and also the Scottish Government’s Diabetes Prevention Working Group.

Jennifer is a member of the NIHR Health Technology Assessment Programme Clinical Evaluation and Trials Board.

As a passionate supporter of improving access to care for patients with obesity, Jennifer has made frequent media appearances discussing obesity, diet, cardiovascular disease and type 2 diabetes.

Qualifications

Member of the Royal College of Physicians 2006

Fellow of the Royal College of Pathologists (Chemical Pathology) 2012

CCT in Chemical Pathology and Metabolic Medicine 2012

 

View all (35) »